MedPath

Paclib

Brand Name: Paclib

Generic Name: Paclitaxel

Active
Registration Number

DR-XY40175

Dosage Form

Concentrate Solution (IV)

Issuance Date

April 14, 2021

Expiry Date

October 14, 2026

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength6 mg/ mL
Packaging5 mL & 16.67 mL Type I Clear Colorless Glass Vial with secondary box

Classification

C
Classification
Prescription Drug (RX)
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

PaclitaxelActive
Monograph: Paclitaxel

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform